96315-53-6

Usage

Uses

Used in Pharmaceutical Industry:
Huzhangoside D is used as an anticancer agent for its ability to inhibit the growth of cancer cells. It targets various cellular pathways and mechanisms, making it a potential candidate for cancer treatment.
Used in Anti-Inflammatory Applications:
Huzhangoside D is used as an anti-inflammatory agent due to its capacity to reduce inflammation in the body, which can be beneficial in treating various inflammatory conditions.
Used in Antioxidant Formulations:
Huzhangoside D is used as an antioxidant in formulations designed to protect against oxidative stress, which can contribute to various diseases and aging processes.
Used in Cardiovascular Health Products:
Huzhangoside D is used as a cardiovascular health promoter, given its potential to support heart health and prevent related diseases by reducing inflammation and oxidative stress.
These applications highlight the versatility of Huzhangoside D in different areas of health and medicine, emphasizing its potential as a valuable compound for future therapeutic development.

Downstream Products

• 109606-00-0 methyl α-L-rhamnopyranosyl-1-4-β-D-glucopyranosyl-1-6-(α and β)-D-glucopyranoside 
• 75799-17-6 C₄₆H₇₄O₁₅ 
• 10323-20-3 D-Arabinose 
• 50-69-1 D-ribose 
• 3615-41-6 L-Rhamnose 
• 50-99-7 D-glucose 
• 465-99-6 hedaragenin 

Relevant academic research and scientific papers

Studies on the constituents of Clematis species. VI. The constituents of Clematis stans SIEB et ZUCC

From the roots of Clematis stans three new oleanane-type triterpenoid saponins named clemastanoside A, B and C, and two new lignan glycosides named clemastanin A and B, have been isolated together with three known triterpenoid saponins, huzhangoside B, C and D, and three known lignan glycosides, (+)-lariciresinol 4-O-β-D-glucopyranoside, (+)-lariciresinol 4'- O-β-D-glucopyranoside and (+)-pinoresinol 4,4'-O-bis-β-D-glucopyranoside. In addition, from the leaves, four new oleanane-type triterpenoid saponins, named clemastanoside D, E, F and G, have been isolated together with five known triterpenoid saponins, hederasaponin B, kizutasaponin K12, huzhangoside B, sieboldianoside B and huzhangoside D, and three known flavonoids, isoquercitrin, ratin and quercetin 3-O-β-D-glucuronopyranoside. The structures of the new compounds were elucidated based on chemical and physicochemical evidence as follows: clemastanoside A, 3-O-β-D- ribopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl oleanolic acid 28-O-(4-O-acetyl)-α-L-rhamnopyranosyl-(1→4)-β-D- glucopyranosyl-(1→6)-β-D-glucopyranosyl ester (terminal rhamnosyl 4-O- acetate of huzhangoside B); clemastanoside B and C, 3-O-β-D-xylopyranosyl- and 3-O-β-D-ribopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-β-D- galactopyranosyl oleanolic acid 28-O-α-L-rhamnopyranosyl-(1→4)-β-D- glucopyranosyl-(1→6)-β-D-glucopyranosyl ester, respectively; clemastanoside D, 3-O-β-D-ribopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L- arabinopyranosyl hederagenin 28-O-β-D-glucopyranosyl ester; clemastanoside E, F and G, terminal rhamnosyl 4-O-, 3-O- and 2-O-acetate of 3-O-β-D- ribopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl hederagenin 28-O-α-L-rhamno-pyranosyl-(1→4)-β-D-glucopyranosyl-(1→6]-β- D-glucopyranosyl ester, respectively; clemastanin A, (7S,8R)-3-methoxy- 3',4,9,9'-tetrahydroxy-4',7-epoxy-5',8-lignan 3'-O-β-D-glucopyranoside; clemastanin B, (+)-lariciresinol 4,4'-O-bis-β-D-glucopyranoside.